Compare VECO & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VECO | NVAX |
|---|---|---|
| Founded | 1945 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.1B |
| IPO Year | 1994 | 1995 |
| Metric | VECO | NVAX |
|---|---|---|
| Price | $29.44 | $6.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 8 |
| Target Price | ★ $28.00 | $9.75 |
| AVG Volume (30 Days) | 670.8K | ★ 3.3M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.83 | ★ 2.07 |
| Revenue | $681,408,000.00 | ★ $1,064,651,000.00 |
| Revenue This Year | N/A | $58.91 |
| Revenue Next Year | $9.81 | N/A |
| P/E Ratio | $35.26 | ★ $3.22 |
| Revenue Growth | N/A | ★ 20.27 |
| 52 Week Low | $16.92 | $5.01 |
| 52 Week High | $34.45 | $11.55 |
| Indicator | VECO | NVAX |
|---|---|---|
| Relative Strength Index (RSI) | 43.73 | 43.34 |
| Support Level | $28.70 | $6.36 |
| Resistance Level | $33.41 | $6.76 |
| Average True Range (ATR) | 1.28 | 0.22 |
| MACD | -0.27 | 0.05 |
| Stochastic Oscillator | 10.83 | 47.39 |
Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for its customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.